본문으로 건너뛰기
← 뒤로

Synthesis of ‑Substituted Acenaphtho[1,2‑]pyrroles and Dibenzo[]indoles with Promising Antileukemic Activity from Morita-Baylis-Hillman Adducts.

1/5 보강
ACS omega 📖 저널 OA 100% 2021: 1/1 OA 2022: 1/1 OA 2023: 5/5 OA 2024: 4/4 OA 2025: 53/53 OA 2026: 70/70 OA 2021~2026 2026 Vol.11(10) p. 16590-16602 OA
Retraction 확인
출처

Arantes J, Rodrigues MT, Rosendo G, Porreca R, Vicari HP, Santos H

📝 환자 설명용 한 줄

This study investigates a novel synthetic pathway for -substituted polycyclic heterocycles with potential antileukemic activity.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Arantes J, Rodrigues MT, et al. (2026). Synthesis of ‑Substituted Acenaphtho[1,2‑]pyrroles and Dibenzo[]indoles with Promising Antileukemic Activity from Morita-Baylis-Hillman Adducts.. ACS omega, 11(10), 16590-16602. https://doi.org/10.1021/acsomega.5c11609
MLA Arantes J, et al.. "Synthesis of ‑Substituted Acenaphtho[1,2‑]pyrroles and Dibenzo[]indoles with Promising Antileukemic Activity from Morita-Baylis-Hillman Adducts.." ACS omega, vol. 11, no. 10, 2026, pp. 16590-16602.
PMID 41867511 ↗

Abstract

This study investigates a novel synthetic pathway for -substituted polycyclic heterocycles with potential antileukemic activity. The strategy employs Morita-Baylis-Hillman (MBH) adducts derived from polycyclic 1,2-diketones such as acenaphthoquinone and phenanthrene-9,10-dione. The key steps involve acetylation of the MBH adducts followed by cyclization with primary amines to afford -heterocycles, specifically acenaphtho-[1,2-]-pyrroles and dibenzo-[]-indoles. The synthesized compounds were evaluated in vitro against leukemia cell lines (Jurkat and NB4). Several derivatives exhibited promising activity, with compound 4b showing particularly strong potency against the NB4 cell line. Overall, this work advances the development of novel antileukemic agents and underscores the potential of -substituted polycyclic heterocycles in leukemia therapy.
🟢 PMC 전문 열기